newsfilter
← Latest News
GlobeNewswire·

EPO Decision to Grant European Patent for Rencofilstat Further Strengthens Hepion's Patent Portfolio

– Patent Covers 38 European Countries – – Rencofilstat's Exclusivity May Extend into 2048 – EDISON, N.J., March 02, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage